SKELREGEN

SkelRegen is a new approach to musculoskeletal care appears to be on the horizon with the recent formation of a company, SkelRegen, aiming to regenerate human bone and other skeletal tissue.

#SimilarOrganizations #More

SKELREGEN

Industry:
Biotechnology Health Care Life Science Medical

Status:
Active


Similar Organizations

y2x-life-sciences-logo

Y2X Life Sciences

Y2X Life Sciences develops and creates improvement on disinfectants to prevent transmission of disease.

More informations about "SkelRegen"

SkelRegen - Crunchbase Company Profile & Funding

Organization. SkelRegen . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. ... SkelRegen is a new approach to musculoskeletal care appears โ€ฆSee details»

Skelregen Company Profile 2024: Valuation, Funding & Investors

Skelregen General Information Description. Developer of patient-specific bone implants intended for maxillofacial reconstruction. The company utilizes 3D printing technology to create โ€ฆSee details»

SkelRegen Company Profile | Management and Employees List

SkelRegen, LLC is the first company to identify not one, but multiple small molecules that are osteoinductive and target different aspects of the musculoskeletal tissue formation pathway. โ€ฆSee details»

Stephen R. La Neve, Founder & CEO - Musculoskeletal New โ€ฆ

SkelRegen is the first company to identify multiple osteoinductive small molecule families that leverage repurposed drugs and novel chemical entities; are delivered on a collagen sponge to โ€ฆSee details»

iTIC Incubator - IIT Hyderabad

SkelRegen is trying to fulfill the huge demand for biomaterial supporting natural bone growth with self-degradation property to avoid multiple surgeries and adequate mechanical strength. Value โ€ฆSee details»

SkelRegen - Drug pipelines, Patents, Clinical trials - Synapse

Explore SkelRegen with its drug pipeline, therapeutic area, technology platform, .See details»

Georgia Research Alliance - GRA

SkelRegen is a drug discovery company focused on ways to enhance bone and cartilage formation and accelerate the healing of bone fractures. The company currently has three drug โ€ฆSee details»

SkelRegen - Overview, News & Competitors | ZoomInfo.com

SkelRegen, LLC is the first company to identify not one, but multiple small molecules that are osteoinductive and target different aspects of the musculoskeletal tissue formation pathway. โ€ฆSee details»

SkelRegen - Tech Stack, Apps, Patents & Trademarks - Crunchbase

SkelRegen focus on newly identified small molecules that target different aspects of the skeletal tissue formation pathway.See details»

SkelRegen - Crunchbase

Organization. SkelRegen . Connect to CRM . Save . Summary People Signals & News Similar Companies. Similar Companies. Edit Similar Companies Section. Companies like SkelRegen โ€ฆSee details»

New Company, SkelRegen, LLC, Aims to Regenerate Skeletal Tissue

Oct 8, 2012 SkelRegen results from a collaboration between Scott D. Boden, MD, Chief Medical Officer at the Emory University Orthopaedic & Spine Hospital and Professor of Orthopaedics, โ€ฆSee details»

SkelRegen's new CEO has been there since company's founding.

Jan 1, 2014 SkelRegen LLC has a new leader. The West Chester, Pa.-based company has appointed Todd F. La Neve, J.D., as CEO, replacing Stephen R. La Neve, who will serve as co โ€ฆSee details»

New Company Aims to Regenerate Skeletal Tissue - CNBC

Oct 5, 2012 The company, called SkelRegen, LLC, has already identified several compounds that it believes could transform musculoskeletal care. WEST CHESTER, Pa.---- A new โ€ฆSee details»

SkelRegen Forms With Focus on Musculoskeletal Care

A new company โ€” SkelRegen โ€” has formed to create musculoskeletal solutions in orthopedics, according to a Herald report. SkelRegen Forms With Focus on Musculoskeletal Care Becker's โ€ฆSee details»

SkelRegen Continues to Gain Traction in Skeletal Tissue ... - BioSpace

Apr 2, 2013 SkelRegen is the first company to focus on newly identified small molecules that target different aspects of the skeletal tissue formation pathway. The results of the study โ€ฆSee details»

SkelRegen Continues to Gain Traction in Skeletal Tissue โ€ฆ

Apr 2, 2013 SkelRegen is the first company to focus on newly identified small molecules that target different aspects of the skeletal tissue formation pathway. The results of the study โ€ฆSee details»

SkelRegen Continues to Gain Traction in Skeletal Tissue โ€ฆ

WEST CHESTER, Pa., April 2, 2013 /PRNewswire/ -- SkelRegen, LLC continues to lead the way in musculoskeletal tissue regeneration. SkelRegen Co-Founder and Chief Medical, Science & โ€ฆSee details»

Former Medtronic presidentโ€™s new orthopaedic startup uses small ...

Oct 9, 2012 A former Medtronic president and the director of Emory University Orthopaedics and Spine Center have launched a biotechnology company to develop molecular compounds. The โ€ฆSee details»

SKELREGEN PRIVATE LIMITED Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for SKELREGEN PRIVATE LIMITED of Hyderabad, Telangana. Get the latest business insights from Dun & โ€ฆSee details»

linkstock.net © 2022. All rights reserved